Application Notes & Case Studies
-
Efficient Data Aggregation & Oversight: A CRO Success Story
4/22/2024
Explore how a full-service CRO & tech-driven life sciences provider streamlined data aggregation & clinical trial oversight, yielding significant time and cost savings.
-
Breaking The Mold: How R Is Revolutionizing CSR Generation
4/22/2024
The open-source statistical programming language R is becoming more popular in the life sciences sector for clinical study report submissions due to its cost-effectiveness, inclusivity, and collaboration.
-
Consolidating Clinical Supply Chain Operations With GxP Inventory
4/18/2024
A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
Patient Engagement: Early Cancer Detection Blood Draw
4/17/2024
Discover how we aided a pharmaceutical company in enrolling participants for a Phase III trial, DETECT-ASCEND 2, focused on Plasma-Based CancerSEEK Testing for early cancer detection.
-
RTSM: Randomization And Cohort Management, IP Inventory Management
4/17/2024
Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.
-
Cutting Red Tape: Direct Data Capture In Clinical Trials
4/12/2024
Say goodbye to duplicate work in clinical trials. Discover how Direct Data Capture revolutionizes research, benefiting patients, sponsors, and sites while streamlining processes.
-
The Business Case For EHR eSource In Clinical Trials
4/12/2024
Examine how manual data collection challenges prompted the adoption of an eSource solution that streamlined data entry, saving time and costs, reducing errors, and accelerating a multicenter phase 2 trial.
-
Patient Caregiver Network Improves Post-Seizure Trial Data
3/26/2024
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
Rare Disease Prioritization Model And Landscape Analysis
3/15/2024
Uncover how a global pharmaceutical company seeking to identify promising indications among rare diseases to develop preclinical candidate molecules received an in-depth disease analysis to guide its strategic decision-making.
-
Streamlining Study Start-Up For Accelerated Drug Development
2/20/2024
Discover how we accelerated a Phase 1 study’s start-up time by 70%! This case study shares insights on streamlining communication, strategic planning, and more.